These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 36919200)

  • 1. Detection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in the air near patients using noninvasive respiratory support devices.
    Besen BAMP; Bruna CQM; Ciofi-Silva CL; Correa MCM; Graziano KU; Paula AV; Yeh-Li H; Joelsons D; Mendes PV; Bubach Carvalho L; Moura MLDN; Guimarães T; Costa SF
    Infect Control Hosp Epidemiol; 2023 May; 44(5):843-845. PubMed ID: 36919200
    [No Abstract]   [Full Text] [Related]  

  • 2. An overview of research on air and environmental contamination with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings.
    Kanamori H
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):130-133. PubMed ID: 33298221
    [No Abstract]   [Full Text] [Related]  

  • 3. Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020.
    Kotwa JD; Jamal AJ; Mbareche H; Yip L; Aftanas P; Barati S; Bell NG; Bryce E; Coomes E; Crowl G; Duchaine C; Faheem A; Farooqi L; Hiebert R; Katz K; Khan S; Kozak R; Li AX; Mistry HP; Mozafarihashjin M; Nasir JA; Nirmalarajah K; Panousis EM; Paterson A; Plenderleith S; Powis J; Prost K; Schryer R; Taylor M; Veillette M; Wong T; Zoe Zhong X; McArthur AG; McGeer AJ; Mubareka S
    J Infect Dis; 2022 Mar; 225(5):768-776. PubMed ID: 34850051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among laboratory staff: Safe handling of coronavirus disease 2019 (COVID-19) samples.
    Hartard C; Agrinier N; Franck P; Prin-Mathieu C; Debourgogne A; Venard V; Schvoerer E; Jeulin H
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1738-1740. PubMed ID: 34287110
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a healthcare worker to a cohort of immunosuppressed patients during the SARS-CoV-2 omicron variant surge, California, 2022.
    Karan A; Ferguson J; Salinas JL
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):156-157. PubMed ID: 35794737
    [No Abstract]   [Full Text] [Related]  

  • 6. Absence of long-range severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a highly infectious patient with undiagnosed coronavirus disease 2019 (COVID-19) in a positive-pressure room.
    Rhee C; Baker MA; Tucker R; Klompas M
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):108-109. PubMed ID: 34287114
    [No Abstract]   [Full Text] [Related]  

  • 7. Can testing the environment for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) be a signal for coronavirus disease 2019 (COVID-19) cases among nursing home staff?
    Gussin GM; Singh RD; Coimbra Ibraim I; Saavedra R; Tjoa TT; Curtis M; Nguyen KP; Messaoudi I; Huang SS
    Infect Control Hosp Epidemiol; 2023 May; 44(5):847-848. PubMed ID: 36573360
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence rate of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among nurses in coronavirus disease 2019 (COVID-19) units versus non-COVID-19-units at a large academic medical center.
    Rivera F; Huerta S; Ahn KW; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2022 Feb; 43(2):257-259. PubMed ID: 34338169
    [No Abstract]   [Full Text] [Related]  

  • 9. May we learn a useful lesson from prevention rules against severe acute respiratory coronavirus virus 2 (SARS-CoV-2)?
    Corbellini S; De Francesco MA; Caruso A
    Infect Control Hosp Epidemiol; 2021 Oct; 42(10):1290-1291. PubMed ID: 32962794
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory virus coinfections with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) continue to be rare one year into the coronavirus disease 2019 (COVID-19) pandemic in Alberta, Canada (June 2020-May 2021).
    Kanji JN; Zelyas N; Pabbaraju K; Granger D; Wong A; Murphy SA; Buss E; MacDonald C; Berenger BM; Diggle MA; Marshall NC; Conly JM; Tipples G
    Infect Control Hosp Epidemiol; 2023 May; 44(5):805-808. PubMed ID: 34866560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient.
    Hughes CM; Gregory GP; Pierce AB; Druce JD; Catton M; Chong B; Sherry NL; Graham M; Chen M; Salvaris R; Eise N; Lee JYH; McQuilten Z; Crouch S; Looker C; Korman TM; Stuart RL
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):820-822. PubMed ID: 33736721
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among PCR-positive air samples from hospital rooms and community isolation facilities.
    Ong SWX; Tan YK; Coleman KK; Tan BH; Leo YS; Wang DL; Ng CG; Ng OT; Wong MSY; Marimuthu K
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1327-1332. PubMed ID: 33487210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among health careworkers (HCWs) during three waves of the coronavirus disease 2019 (COVID-19) pandemic in Germany: Results of an anonymous survey.
    Schulz-Stübner S; Pielert E
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1742-1744. PubMed ID: 34338178
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to "Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) surface contamination in staff common areas and impact on healthcare worker infection: Prospective surveillance during the coronavirus disease 2019 (COVID-19) pandemic".
    Weber DJ; Sickbert-Bennett EE; Warren BG; Anderson DJ
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):161-162. PubMed ID: 35383551
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistent infection with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a patient with untreated human immunodeficiency virus (HIV).
    Zhabokritsky A; Mubareka S; Kozak RA; Maguire F; Yip L; Yip P; Powis J
    Infect Control Hosp Epidemiol; 2023 Feb; 44(2):350-351. PubMed ID: 35591771
    [No Abstract]   [Full Text] [Related]  

  • 16. Retesting for severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Patterns of testing from a large US healthcare system.
    Kennedy AJ; Hilmes MK; Waddell L; Bartow AB; Baxter CM; Hadi CM; Snyder GM; Merlin JS
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):1023-1025. PubMed ID: 32772941
    [No Abstract]   [Full Text] [Related]  

  • 17. Ventilated patient headboards in the postanesthesia care unit as an alternative to universal preprocedural severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing.
    Penney JA; Doron S
    Infect Control Hosp Epidemiol; 2023 Apr; 44(4):686-688. PubMed ID: 36134433
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible contact transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings in Japan, 2020-2021.
    Kurosu H; Watanabe K; Kurosawa K; Nakashita M; Kasamatsu A; Nakamura H; Yamagishi T; Mitsuhashi Y; Yano K; Hachiya Y; Odani T; Amishima M; Nekomiya Y; Matsui T; Yamada M; Kamiyama K; Kikuchi T; Takadate K; Watanabe C; Furusawa Y; Kase K; Hyodo Y; Suzuki H; Matsunaga T; Hori H; Kanoh M; Miyake Y; Yamada M; Kobayashi Y; Sugai M; Suzuki M; Sunagawa T
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1296-1298. PubMed ID: 34039453
    [No Abstract]   [Full Text] [Related]  

  • 19. Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2).
    Lüsebrink J; Schildgen V; Schildgen O
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1529-1532. PubMed ID: 33213555
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination remains the first choice to control the spread of delta and other variants of severe acute respiratory coronavirus virus 2 (SARS-CoV-2).
    Liang Q; Sun C; Liu H; Zhang X; Ayaz Ahmed M; Misra S; Uy JPN; Shaikh MB
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1749-1750. PubMed ID: 34353390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.